
Karthikeyan Murugesan
Advertisement
Articles by Karthikeyan Murugesan

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
2
Sevabertinib Monotherapy Elicits Durable Responses in HER2-Mutant NSCLC
3
Pembrolizumab/Chemotherapy Improves Survival in Recurrent PROC
4
Zongertinib Maintains Efficacy Benefit in First-line HER2-Mutated NSCLC
5